GAMMA Investing LLC Grows Position in The Cooper Companies, Inc. (NASDAQ:COO)

GAMMA Investing LLC boosted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 9.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,605 shares of the medical device company’s stock after acquiring an additional 304 shares during the quarter. GAMMA Investing LLC’s holdings in Cooper Companies were worth $331,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in COO. Commonwealth Equity Services LLC lifted its holdings in Cooper Companies by 0.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock worth $1,362,000 after buying an additional 118 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in Cooper Companies by 206.3% in the second quarter. Acadian Asset Management LLC now owns 2,205 shares of the medical device company’s stock valued at $191,000 after purchasing an additional 1,485 shares in the last quarter. Varma Mutual Pension Insurance Co acquired a new position in Cooper Companies in the second quarter valued at approximately $1,746,000. Oak Thistle LLC purchased a new position in Cooper Companies in the second quarter valued at approximately $944,000. Finally, Quest Partners LLC raised its holdings in Cooper Companies by 690.9% during the second quarter. Quest Partners LLC now owns 19,298 shares of the medical device company’s stock worth $1,685,000 after purchasing an additional 16,858 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Up 1.3 %

COO stock opened at $93.01 on Tuesday. The stock has a market capitalization of $18.56 billion, a PE ratio of 47.70, a price-to-earnings-growth ratio of 2.52 and a beta of 0.99. The company has a fifty day moving average of $98.91 and a 200-day moving average of $98.86. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter last year, the firm earned $0.87 earnings per share. The firm’s revenue was up 9.8% compared to the same quarter last year. As a group, analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company upped their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley cut their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Citigroup cut their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.